Bottom line
SPXS vs TBXU: the short answer
SPXS (Direxion Daily S&P 500(R) Bear 3X ETF) and TBXU (Direxion Daily Biotech Top 5 Bull 2X ETF) share a meaningful slice of their top holdings — about 55% by weight.
TBXU is cheaper at 0.98% vs 1.04% — a difference of $6.00 a year per $10,000 invested.
Updated Nov 19, 2026
SPXS vs TBXU side by side
| SPXS | TBXU | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.04% | 0.98% |
| Annual cost per $10k | $104 | $98 |
| 10-yr cost on $10k (prospectus) | $1,271 | $5,645 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −41.5% | — |
| 5-yr return (annualized) | −36.5% | — |
| 10-yr return (annualized) | −41.3% | — |
| Best quarter | +51.2% | — |
| Worst quarter | −51.2% | — |
| Net assets (fund) | $451.4M | $2.6M |
| Number of holdings | 11 | 10 |
| Portfolio turnover | % | 69% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of SPXS's top 11 holdings also appear in TBXU's top 10.
| Holding | SPXS | TBXU |
|---|---|---|
| Dreyfus | 35.74% | 21.64% |
| Goldman Financial | 30.50% | 29.36% |
| Goldman Sachs Liq Es Fd A | 10.02% | 6.23% |
| N/a | -0.11% | 0.62% |
| N/a | -0.76% | 0.62% |
| N/a | -0.99% | 0.62% |
| N/a | -1.51% | 0.62% |
| N/a | -1.51% | 0.62% |
| N/a | -1.89% | 0.62% |
| N/a | -1.98% | 0.62% |
Source: SEC Form N-PORT
SPXS top 10
- Dreyfus — 35.74%
- Goldman Financial — 30.50%
- Dreyfus — 10.31%
- Goldman Sachs Liq Es Fd A — 10.02%
- N/a — -0.11%
- N/a — -0.76%
- N/a — -0.99%
- N/a — -1.51%
- N/a — -1.51%
- N/a — -1.89%
TBXU top 10
- Goldman Financial — 29.36%
- Dreyfus — 21.64%
- Regeneron Pharmaceuticals Inc — 9.09%
- Amgen Inc — 7.95%
- Vertex Pharmaceuticals Inc — 7.84%
- Gilead Sciences Inc — 7.58%
- Argenx Se - Adr — 6.98%
- Goldman Sachs Liq Es Fd A — 6.23%
- N/a — 2.83%
- N/a — 0.62%
FAQ
What is the difference between SPXS and TBXU?
SPXS (Direxion Daily S&P 500(R) Bear 3X ETF) and TBXU (Direxion Daily Biotech Top 5 Bull 2X ETF) share a meaningful slice of their top holdings — about 55% by weight. TBXU is cheaper at 0.98% vs 1.04% — a difference of $6.00 a year per $10,000 invested.
Which is cheaper, SPXS or TBXU?
TBXU has the lower expense ratio (0.98%).
Should I own both SPXS and TBXU?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.